Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3949/ccjm.87a.ccc021 http://scihub22266oqcxt.onion/10.3949/ccjm.87a.ccc021 32393596!ä!32393596       Cleve+Clin+J+Med 2020 ; ä (ä): ä Nephropedia Template TP {{tp|p=32393596|t=2020. COVID-19 and pulmonary hypertension |pdf=|usr=}}{{32393596}} gab.com Text COVID-19 and pulmonary hypertension JO: Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393596 #FOAvip Pulmonary hypertension (PH) is a pulmonary vascular disease characterized by pulmonary arterial remodeling and vasoconstriction leading to elevated pulmonary artery pressure and, ultimately, right heart failure. So far, few cases of COVID-19 disease in patients with PH have been reported. Caution is warranted in interpreting this observation as data are evolving and several factors may influence the number of reported cases of PH and COVID-19. Social distancing and quarantine could play a role, especially for patients with chronic diseases who might be more vigilant of their potential for respiratory infection. In addition, PH is a rare disease, and because testing is not universal, we could be underestimating the number of cases. Other hypothetical factors to consider are the underlying pathophysiology of PH and the medications used to treat PH and their implications in COVID-19. Twit Text FOAVip COVID-19 and pulmonary hypertension ????Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393596 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32393596 #FOAvip English Wikipedia <ref>{{Cite pmid|32393596}}</ref> COVID-19 and pulmonary hypertension #MMPMID32393596 Farha S Cleve Clin J Med 2020[May]; ä (ä): ä PMID32393596show ga Pulmonary hypertension (PH) is a pulmonary vascular disease characterized by pulmonary arterial remodeling and vasoconstriction leading to elevated pulmonary artery pressure and, ultimately, right heart failure. So far, few cases of COVID-19 disease in patients with PH have been reported. Caution is warranted in interpreting this observation as data are evolving and several factors may influence the number of reported cases of PH and COVID-19. Social distancing and quarantine could play a role, especially for patients with chronic diseases who might be more vigilant of their potential for respiratory infection. In addition, PH is a rare disease, and because testing is not universal, we could be underestimating the number of cases. Other hypothetical factors to consider are the underlying pathophysiology of PH and the medications used to treat PH and their implications in COVID-19. äCOVID-19 and pulmonary hypertension (epmc).pdf DeepDyve Pubget Overpricing